January 19, 2015

Plenary Session
Greetings, Y. Rozenman, President, Israel Heart Society

P. Asfar, France

Sponsored by Lilly lilly - logo
The immediate effect of new antiplatelet agents in patients with ACS: Should we preload the patient?
E. Lev, Israel

The contemporary use of new antiplatelet agents: Barriers and clinical benefits
S. Matetzky, Israel

January 20, 2015

Plenary Session
How solid are the guidelines? A critical review of the ACS guidelines
S. Kaul, USA

Case presentation
A. Shimony, Israel

Sponsored by AstraZeneca AstraZeneca logo
Y. Rozenman, Israel

Y. Rozenman, Israel

New and upcoming data regarding Ticagrelor in ACS and PCI
G. Steg, France

Sponsored by Boehringer Ingelheim Boehringer Ingelheim logo
Dabigatran as part of “Triple” therapy in patients suffering from acute coronary syndrome and atrial fibrillation – conclusions from clinical trial and real-world data
A. Pollak, Israel

Sponsored by Pfizer Pfizer Logo small
Comparison of Apixaban, Dabigatran and Rivaroxaban in the acute treatment and prevention of venous thromboembolism
S. Berliner, Israel